George J - Search Results

1

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.

Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Younossi Z, et al. Among authors: george j. Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20. Nat Rev Gastroenterol Hepatol. 2018. PMID: 28930295 Free article. Review.

2

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.

Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M, George J. Chitturi S, et al. Among authors: george j. Hepatology. 2002 Feb;35(2):373-9. doi: 10.1053/jhep.2002.30692. Hepatology. 2002. PMID: 11826411

3

Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.

Hui JM, Kench J, Farrell GC, Lin R, Samarasinghe D, Liddle C, Byth K, George J. Hui JM, et al. Among authors: george j. J Gastroenterol Hepatol. 2002 Aug;17(8):873-81. doi: 10.1046/j.1440-1746.2002.02813.x. J Gastroenterol Hepatol. 2002. PMID: 12164963

4

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, McCaughan GW, George J. Hui JM, et al. Among authors: george j. Gastroenterology. 2003 Dec;125(6):1695-704. doi: 10.1053/j.gastro.2003.08.032. Gastroenterology. 2003. PMID: 14724822

5

Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?

Chitturi S, Farrell GC, George J. Chitturi S, et al. Among authors: george j. J Gastroenterol Hepatol. 2004 Apr;19(4):368-74. doi: 10.1111/j.1440-1746.2003.03252.x. J Gastroenterol Hepatol. 2004. PMID: 15012772 Review.

6

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Hui JM, et al. Among authors: george j. Hepatology. 2004 Jul;40(1):46-54. doi: 10.1002/hep.20280. Hepatology. 2004. PMID: 15239085

7

Hepatic steatosis and the risk of hepatocellular carcinoma in chronic hepatitis C.

Kumar D, Farrell GC, Kench J, George J. Kumar D, et al. Among authors: george j. J Gastroenterol Hepatol. 2005 Sep;20(9):1395-400. doi: 10.1111/j.1440-1746.2005.04007.x. J Gastroenterol Hepatol. 2005. PMID: 16105127

8

Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.

Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J. Bugianesi E, et al. Among authors: george j. Hepatology. 2006 Dec;44(6):1648-55. doi: 10.1002/hep.21429. Hepatology. 2006. PMID: 17133473

9

Pathogenesis of NASH: animal models.

London RM, George J. London RM, et al. Among authors: george j. Clin Liver Dis. 2007 Feb;11(1):55-74, viii. doi: 10.1016/j.cld.2007.02.010. Clin Liver Dis. 2007. PMID: 17544972 Review.

10

Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.

St George A, Bauman A, Johnston A, Farrell G, Chey T, George J. St George A, et al. Among authors: george j. J Gastroenterol Hepatol. 2009 Mar;24(3):399-407. doi: 10.1111/j.1440-1746.2008.05694.x. Epub 2008 Dec 2. J Gastroenterol Hepatol. 2009. PMID: 19067776 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,295 results

Search Page